1. Aerosolizable gold nano-in-micro dry powder formulations for theragnosis and lung delivery
- Author
-
Clarinda Costa, Vasco D. B. Bonifácio, Renato P. Cabral, Teresa Casimiro, Ana Aguiar-Ricardo, Ana M. L. Sousa, Sónia P. Miguel, Ilídio J. Correia, A. Sofia Silva, Marta M. C. G. Silva, and uBibliorum
- Subjects
Chemistry, Pharmaceutical ,Drug Compounding ,Metal Nanoparticles ,Pharmaceutical Science ,Nanoparticle ,Nanotechnology ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Excipients ,Chitosan ,chemistry.chemical_compound ,Cell Line, Tumor ,Nano ,Humans ,Gold nanoparticles ,Particle Size ,Pulmonary delivery ,Lung ,Aerosols ,Dry powder formulation ,chemistry.chemical_classification ,Drug Carriers ,Chemistry ,Biomolecule ,Spray drying ,Dry Powder Inhalers ,Supercritical CO2 ,021001 nanoscience & nanotechnology ,Controlled release ,Nano-in-micro ,0104 chemical sciences ,A549 Cells ,Colloidal gold ,Dry powder ,Gold ,Powders ,Lung cancer ,0210 nano-technology - Abstract
Functionalized gold nanoparticles (AuNPs) have been widely investigated as promising multifunctional nanosystems for the theragnosis of lung cancer, the most common and prominent cause of cancer death worldwide. Nevertheless, nanoparticles are not in appropriate sizes for an accurate deep lung delivery and the lack of locally and effective delivery of therapeutic biomolecules to the deep lungs is, in fact, the major cause of low therapeutic outcome. Herein we incorporate, for the first time, AuNPs into respirable microparticles. AuNPs were functionalized with biocompatible oligo(2-oxazoline)-based optically stable fluorescent coatings, and conjugated with a laminin peptide (YIGSR) for targeted lung cancer delivery. These POxylated AuNPs were then incorporated into a chitosan matrix by a clean process, supercritical CO2-assisted spray drying (SASD), yielding nano-in-micro clean ultrafine dry powder formulations. The engineered formulations present the adequate morphology and flowability to reach the deep lung, with aerodynamic sizes ranging 3.2–3.8 μm, and excellent fine particle fraction (FPF) (FPF of 47% for CHT-bearing targeted AuNPs). The optimal biodegradation and release profiles enabled a sustained and controlled release of the embedded nanoparticles, with enhanced cellular uptake, opening new prospects for future lung theragnosis.
- Published
- 2017
- Full Text
- View/download PDF